Experiments for taxon Voacanga chalotiana (APOCYNACEAE)

Experiments (16 results)

Filters
Worktypes (14)
9
8
8
6
5
5
4
3
3
2
1
1
1
1
No match
Pharmacology (5)
3
3
1
1
8
No match
Compounds (9)
8
2
1
1
1
1
1
1
1
No match
Organisms (9)
5
2
2
2
1
1
1
1
1
No match
16 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
617602
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
324870
ISOLATION AND IDENTIFICATION OF
Voacanga chalotiana (APOCYNACEAE)
VOBTUSINE
324869
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Voacanga chalotiana (APOCYNACEAE)
QUIMBELINE
617599
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTIARRHYTHMIC ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
617600
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
VASODILATOR ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
611472
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
1035162
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Voacanga chalotiana (APOCYNACEAE)
VOBTUSAMINE
999152
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Voacanga chalotiana (APOCYNACEAE)
VOBTUSINE,3-EPSILON-HYDROXY:
614050
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTIHYPERTENSIVE ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
283596
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Voacanga chalotiana (APOCYNACEAE)
APOCUANZINE,DECARBOMETHOXY:
617598
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTIHYPERTENSIVE ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
611471
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTIHYPERTENSIVE ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
815001
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Voacanga chalotiana (APOCYNACEAE)
VOACHALOTINE,3-HYDROXY:
412713
CMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURESTEREOCHEMISTRY DETERMINED FOR
Voacanga chalotiana (APOCYNACEAE)
VOACHALOTINE,19-20-DEHYDRO: 17-O-ACETYL:
999153
ISOLATION AND IDENTIFICATION OF
Voacanga chalotiana (APOCYNACEAE)
VOBTUSINEAMATAINE
617601
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Voacanga chalotiana (APOCYNACEAE)
CUANZINE